47 results on '"Akizuki, Keiichi"'
Search Results
2. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
3. Whole-genome landscape of adult T-cell leukemia/lymphoma
4. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
5. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia
6. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
7. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
8. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
9. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia
10. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan
11. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
12. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
13. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
14. The effect of CARD11 mutation and HBZ expression accelerated lymphoproliferative diseases and formed the pathological basis for adult T-cell leukemia/lymphoma
15. Ursodeoxycholic acid markedly promotes the absorption of microemulsion‐formulated cyclosporine A: A case report
16. Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
17. Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
18. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan
19. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma
20. CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
21. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
22. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms
23. TP53 and PTEN Mutations Were Shared in Concurrent Germ Cell Tumor and Acute Megakaryoblastic Leukemia
24. Depletion of Neoplastic CD11b Positive Cells in Jak2V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis
25. The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms
26. Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation
27. TET2 Mutation Associated with Organ Infiltrations in ATLL
28. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma.
29. Ursodeoxycholic acid markedly promotes the absorption of microemulsion‐formulated cyclosporine A: A case report.
30. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia
31. Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice
32. Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
33. 7. Current Treatment for Leukemia
34. TET2 mutation in diffuse large B-cell lymphoma
35. Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice
36. Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)
37. TYK2 Is Essential for IFNα-Induced Resolution of MPN Features in a Murine Jak2V617F PMF Model
38. Mogamulizumab for ATLL in Clinical Practice
39. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma
40. Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F
41. DEVELOPMENT OF THE VULNERABLE PEOPLE SUPPORTING SYSTEM FOR A TSUNAMI REFUGE AREA
42. CARD11Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
43. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.
44. TET2Mutation Associated with Organ Infiltrations in ATLL
45. Haploinsufficiency of CALRConfers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the CalrMutation
46. [Programs for Continuing Medical Education 2016: B Session: 7. Current Treatment for Leukemia].
47. [A case of neurolymphomatosis: peripheral neuropathy induced by diffuse large B-cell lymphoma without any abnormal accumulation observed on early positron emission tomography-computed tomography].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.